Canlyniadau Chwilio - Josef Mališ

  • Dangos 1 - 3 canlyniadau o 3
Mireinio'r Canlyniadau
  1. 1
    Randomized Trial of Prophylactic Granulocyte Colony-Stimulating Factor During Rapid COJEC Induction in Pediatric Patients With High-Risk Neuroblastoma: The European HR-NBL1/SIOPEN Study

    Randomized Trial of Prophylactic Granulocyte Colony-Stimulating Factor During Rapid COJEC Induction in Pediatric Patients With High-Risk Neuroblastoma: The European HR-NBL1/SIOPEN... gan Ruth Ladenstein, Dominique Valteau‐Couanet, Penelope Brock, Isaac Yaniv, Victoria Castel, Geneviève Laureys, Josef Mališ, Vassilios Papadakis, Ana Lacerda, Ellen Ruud, Per Kogner, Miklós Garami, Walentyna Balwierz, Henrik Schrøeder, Maja Beck‐Popovic, G. Schreier, David Machin, Ulrike Pötschger, Andrew D.J. Pearson

    Cyhoeddwyd 2010
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Influence of Surgical Excision on the Survival of Patients With Stage 4 High-Risk Neuroblastoma: A Report From the HR-NBL1/SIOPEN Study

    Influence of Surgical Excision on the Survival of Patients With Stage 4 High-Risk Neuroblastoma: A Report From the HR-NBL1/SIOPEN Study gan Keith Holmes, Ulrike Pötschger, Andrew D.J. Pearson, Sabine Sarnacki, Giovanni Cecchetto, J Gómez-Chacón, Roly Squire, Enrique Freud, Adam Bysiek, Lucas Matthyssens, Martin Metzelder, Tom Monclair, Jakob Stenman, Michal Rygl, Lars Melholt Rasmussen, Jean‐Marc Joseph, Sabine Irtan, Stefano Avanzini, Jan Godziński, Kristin Bjørnland, Martin Elliott, Roberto Luksch, Victoria Castel, Shifra Ash, Walentyna Balwierz, Geneviève Laureys, Ellen Ruud, Vassilios Papadakis, Josef Malis̆, Cormac Owens, Henrik Schrøeder, Maja Beck‐Popovic, Toby N. Trahair, Ana Lacerda, Peter F. Ambros, Mark N. Gaze, Kieran McHugh, Dominique Valteau‐Couanet, Ruth Ladenstein

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Frequency and Prognostic Impact of <i>ALK</i> Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1)

    Frequency and Prognostic Impact of <i>ALK</i> Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1) gan Angela Bellini, Ulrike Pötschger, Virginie Bernard, Eve Lapouble, Sylvain Baulande, Peter F. Ambros, Nathalie Auger, Klaus Beiske, Marie Bernkopf, David R. Betts, Jaydutt Bhalshankar, Nick Bown, Katleen De Preter, Nathalie Clément, Valérie Combaret, Jaime Font de Mora, Sally L. George, Irène Jiménez, Marta Jeison, Bárbara Marques, Tommy Martinsson, Katia Mazzocco, Martina Morini, Annick Mühlethaler‐Mottet, Rosa Noguera, Gaëlle Pierron, Maria Rossing, Sabine Taschner‐Mandl, Nadine Van Roy, Aleš Vícha, Louis Chesler, Walentyna Balwierz, Victoria Castel, Martin Elliott, Per Kogner, Geneviève Laureys, Roberto Luksch, Josef Mališ, Maja Beck‐Popovic, Shifra Ash, Olivier Delattre, Dominique Valteau‐Couanet, Deborah A. Tweddle, Ruth Ladenstein, Gudrun Schleiermacher

    Cyhoeddwyd 2021
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: